Sven Mahner

ORCID: 0000-0002-0640-129X · 40 papers in corpus
observational 2026
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08331-4

OBJECTIVE: The study aimed to evaluate the long-term outcomes of surgical management in patients with peritoneal endometriosis, focusing on postoperative pain trajectories, re-operation rates, fertility outcomes, and the potential influence…

2026
·doi:10.6084/m9.figshare.32110074.v1

Supplementary Material 1.

2026
·doi:10.6084/m9.figshare.32110074

Supplementary Material 1.

2026
·doi:10.6084/m9.figshare.32110077.v1

Supplementary Material 2.

2026
·doi:10.6084/m9.figshare.32110077

Supplementary Material 2.

lab-animal 2026
·doi:10.6084/m9.figshare.c.8445471.v1

Abstract Background Endometriosis is a highly prevalent, hormone-driven chronic disease characterized by the growth of endometrial tissue outside the uterine cavity. Despite its impact, the mechanisms underlying the disease’s pathogenesis r…

lab-animal 2026
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-026-01559-4

BACKGROUND: Endometriosis is a highly prevalent, hormone-driven chronic disease characterized by the growth of endometrial tissue outside the uterine cavity. Despite its impact, the mechanisms underlying the disease’s pathogenesis remain po…

lab-animal 2026
·doi:10.6084/m9.figshare.c.8445471

Abstract Background Endometriosis is a highly prevalent, hormone-driven chronic disease characterized by the growth of endometrial tissue outside the uterine cavity. Despite its impact, the mechanisms underlying the disease’s pathogenesis r…

other 2026
Cancers ·doi:10.3390/cancers18132115

Background: High-grade serous ovarian carcinoma (HGSOC) can be subdivided into four prognostic molecular subtypes based on gene expression: C1/Mesenchymal (C1.MES), C2/Immunoreactive (C2.IMM), C4/Differentiated (C4.DIF) and C5/Proliferative…

rct 2025
BMC women's health ·doi:10.1186/s12905-025-03736-w

BACKGROUND: The global increase in interest in endometriosis highlights the importance of further investigations concerning this so-called benign gynecological disease. Owing to their severe presentation of symptoms, patients suffer from an…

observational 2025
Life (Basel, Switzerland) ·doi:10.3390/life15020135

BACKGROUND: Cervical cancer (CC) is the fourth most common cancer diagnosis in women worldwide. Infection with high-risk human papillomavirus (HPV) is a critical but not determinative condition for CC development, as several co-factors modu…

guideline 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-07974-z

Opportunistic salpingectomy is defined as the removal of both fallopian tubes as part of a surgical procedure planned for other reasons. The goal is primary prevention of ovarian cancer. The procedure is offered to patients who are not know…

observational 2025
European radiology ·doi:10.1007/s00330-024-11031-9

OBJECTIVES: With SARS-CoV-2 evolving, disease severity and presentation have changed due to changes in mechanisms of entry and effector site as well as due to effects of vaccination- and/or infection-acquired immunity. We re-assessed fetal …

review 2024
MMW Fortschritte der Medizin ·doi:10.1007/s15006-024-3855-x
observational 2024
Biomedicines ·doi:10.3390/biomedicines12020321

Interleukin-8 (IL-8) is involved in the regulation of inflammatory processes and carcinogenesis. Single-nucleotide polymorphisms (SNPs) within the IL-8 gene have been shown to alter the risks of lung, gastric, or hepatocellular carcinomas. …

observational 2024
International journal of molecular sciences ·doi:10.3390/ijms251910272

Single nucleotide polymorphisms (SNPs) of the IL-16 gene have been reported to influence the risk of several cancers, but their role in ovarian cancer (OC) has not been studied. Using the restriction fragment length polymorphism (PCR-RFLP) …

other 2024
Translational oncology ·doi:10.1016/j.tranon.2024.102116

OBJECTIVES: The chemokine CCL22 is recognized for recruiting immunosuppressive regulatory T-cells (Treg) that contribute to disease progression in various tumor entities helping them to evade the host immune response. Our study aims to iden…

2024
·doi:10.1055/s-0044-1787455
other 2023
MMW Fortschritte der Medizin ·doi:10.1007/s15006-023-2298-0
other 2022
Scientific reports ·doi:10.1038/s41598-022-05785-9

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, t…

review 2022
MMW Fortschritte der Medizin ·doi:10.1007/s15006-022-2175-2
observational 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06419-1

OBJECTIVE: Recent studies revealed intriguing associations between cholecalciferol (D3) and reproductive functions. Seasonal changes of D3 concentrations are well known; however, they are not always considered in the context of reproductive…

observational 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06730-x

PURPOSE: Endometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with endometri…

observational 2021
Cancers ·doi:10.3390/cancers13081764

Epithelial ovarian cancer (EOC) generally responds well to oncological treatments, but the eventual development of a refractory disease is a major clinical problem. Presently, there are no prognostic blood-based biomarkers for the stratific…

review 2021
Cancers ·doi:10.3390/cancers13133349

Gynaecological malignancies represent a heterogeneous group of neoplasms with vastly different aetiology, risk factors, molecular drivers, and disease outcomes. From HPV-driven cervical cancer where early screening and molecular diagnostics…